...Rodney Sinclair; Ernest H. Law; Xingqi Zhang; Fan Zhang; Lynne Napatalung; Samuel H. Zwillich; Brett King; Natasha Mesinkovska Introduction: Patients with alopecia areata (AA) report high levels of dissatisfaction with commonly used treatments. Patient-reported outcomes are essential...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Alopecia areata Google trends Research trends Public knowledge We read with great interest the recent article “A Bibliometrics of the Treatment of Alopecia...

...Wen-Rong Luo; Gan Shen; Li-Hua Yang; Xiao-Hai Zhu Background: Alopecia areata (AA) is an autoimmune disorder characterized by hair loss on the scalp, face, and other body areas. Despite affecting approximately 2% of the global population, there has been no previous bibliometric analysis...

...Ross O'Hagan; Randie H. Kim; Brian J. Abittan; Stella Caldas; Jonathan Ungar; Benjamin Ungar Background: Patients with alopecia areata (AA) may access a wide range of sources for information about AA, including the recently developed ChatGPT. Assessing the quality of health information...

...Kuang-Hsu Lien; Tzong-Yun Ger; Ching-Chi Chi Background: Immune-mediated melanocyte-related pathogenesis in alopecia areata (AA) may cause sensorineural hearing loss (SNHL). However, the relation between AA and SNHL has been unclear. Therefore, we aimed to investigate this association between AA...

...Li-Hsin Wang; Sheng-Hsiang Ma; Ying-Hsuan Tai; Ying-Xiu Dai; Yun-Ting Chang; Tzeng-Ji Chen; Mu-Hong Chen Background: There is growing evidence that patients with alopecia areata (AA) have an increased risk of developing psychiatric comorbidities. However, the relationship between AA and suicidal...

...Tao Zhang; Yingli Nie Background: Alopecia areata (AA) is an autoimmune disease typified by nonscarring hair loss with a variable clinical course. Although there is an increased understanding of AA pathogenesis and progress in its treatments, the outcome of AA patients remains unfavorable...

...-scarring alopecia was 1.99% (k = 12; I 2 = 99%, 95% CI 6.2–34). The prevalence of non-scarring alopecia areata (AA) among IBD was compared to the prevalence of AA in the general population (0.63 vs. 0.1%; p < 0.0001). Similarly, the prevalence of IBD among the scarring and non-scarring alopecia groups...

...Caihong Xin; Xin Sun; Li Lu; Rong Yang; Ling Shan; Yang Wang Background: Alopecia areata (AA) is a common, clinically heterogeneous, immune-mediated, nonscarring hair loss disease with a pathogenesis that is not fully understood. The prevalence of thyroid disease is likely increased among...

...Nawaf Almutairi; Tarek M. Nour; Nasser Haji Hussain Background: Alopecia areata (AA) is a common autoimmune disorder characterized by patchy hair loss. There are many treatments available for AA. However, treatments of severe forms of AA are not satisfactory. Recently, oral Janus kinase (JAK...

...Deepika Yadav; Sujay Khandpur; M. Ramam; Manoj K. Singh; Vinod K. Sharma Background: Androgenetic alopecia (AGA) and alopecia areata (AA) are common causes of alopecia which can sometimes be difficult to differentiate clinically. Horizontal sections of scalp biopsies are used to study non...

...Anna Lyakhovitsky; Sarit Gilboa; Anna Eshkol; Aviv Barzilai; Sharon Baum Background: Alopecia areata is an immune-mediated disease presenting with sudden onset of nonscarring hair loss. Onset is more common earlier in life, and little is known regarding late-onset alopecia areata. Objectives...

.... Alopecia areata Alopecia totalis Alopecia universalis Long-term prognosis Prognostic factors Patients with alopecia totalis (AT) or alopecia universalis (AU) usually have a poor prognosis, and treatment failure is seen in most patients regardless of the type of therapy [ 1 ]. Moreover...

...Yong Hyun Jang; Sun Young Moon; Weon Ju Lee; Seok-Jong Lee; Won Kee Lee; Byung Cheol Park; Hyojin Kim; Do Won Kim Background: No scoring systems to evaluate overall hair loss activity in alopecia areata (AA) have been established. Objective: We sought to develop a measurement tool (Alopecia Areata...

...Delphine Anuset; Geraldine Perceau; Philippe Bernard; Ziad Reguiai Background: In severe alopecia areata (AA), spontaneous recovery is unlikely, and treatment is not standardized. Ob jective: To evaluate the efficacy and safety of methotrexate (MTX) used alone or combined with low- to moderate-dose...

...Ji Won Byun; Jong Hyuk Moon; Chan Yl Bang; Jeonghyun Shin; Gwang Seong Choi Background: Some studies have reported the use of 308-nm excimer laser therapy for treating alopecia areata (AA); however, the effectiveness of this therapy on a theoretical basis has not yet been comparatively analyzed...

...Hesham Zaher; Heba I. Gawdat; Rehab A. Hegazy; Marwa Hassan Background: Alopecia areata (AA) is an immune-mediated disease that targets anagen hair follicles. Despite various therapeutic options, there is no cure for AA. Prostaglandin analogues have been recognized as being capable of inducing...

... that the single nucleotide polymorphism in IL2RA may affect the pathogenesis of alopecia areata (AA). Objective: Our aim was to investigate the link between IL2RA polymorphism and AA in a Chinese population. Methods: We examined 427 patients and 430 controls in this study. The rs3118470 polymorphism was evaluated...

...Rivka Friedland; Rotem Tal; Moshe Lapidoth; Alex Zvulunov; Dan Ben Amitai Background/Objective: Alopecia areata may occur at any age, though usually before the age of 20 years. Treatment often consists of systemic steroids administered as high-dose bolus infusions. This study sought to investigate...

...Genichi Tojo; Taku Fujimura; Mitsuko Kawano; Kouetsu Ogasawara; Yumi Kambayashi; Sadanori Furudate; Masato Mizuashi; Setsuya Aiba T helper 17 cells, characterized by interleukin-17 (IL-17) production, play a critical role in the pathogenesis of autoimmune disease, including alopecia areata (AA...